Formula Grant 15PBJA25GG02345RSAT
- The Virginia Department of Criminal Justice Services (DCJS) was awarded a $723,436 Residential Substance Abuse Treatment (RSAT) for State Prisoners Program Formula Grant by the U.S. Department of Justice's Bureau of Justice Assistance. The grant, authorized under CFDA 16.593, will be used to provide subawards to detention centers, jails, prisons, and aftercare programs across Virginia to deliver evidence-based substance use disorder (SUD) treatment, including medication-assisted treatment (MAT),...
- The West Virginia Division of Administrative Services/Justice and Community Services (DAS/JCS) was awarded a $338,353 Residential Substance Abuse Treatment (RSAT) for State Prisoners Formula Grant from the U.S. Department of Justice's Bureau of Justice Assistance. This 4-year grant, effective October 1, 2023 to September 30, 2027, will enable DAS/JCS to sub-grant funds to the West Virginia Division of Corrections and Rehabilitation (DCR) to continue supporting 18 RSAT therapeutic communities...
- The Department of Justice Office of Justice Programs Bureau of Justice Assistance awarded $322,369 under the Residential Substance Abuse Treatment for State Prisoners (RSAT) program (CFDA 16.593) to the Massachusetts Department of Public Safety Executive Office of Public Safety. The funding supports evidence-based substance use disorder treatment and prevention programs delivered through the Massachusetts Department of Public Health to reduce recidivism and overdose deaths. Services include...
- The West Virginia Division of Corrections and Rehabilitation (DCR) received a $249,507 Residential Substance Abuse Treatment (RSAT) for State Prisoners Program formula grant from the U.S. Department of Justice's Bureau of Justice Assistance (CFDA 16.593). This four-year grant, awarded on October 1, 2024, supports the DCR's efforts to provide evidence-based substance use disorder (SUD) treatment and rehabilitation services to incarcerated individuals in West Virginia. The funding allows the DCR...
- The Rhode Island Department of Corrections received a $197,621 Formula Grant award from the U.S. Department of Justice's Bureau of Justice Assistance under the Residential Substance Abuse Treatment (RSAT) for State Prisoners Program (CFDA 16.593). This 4-year grant, effective October 1, 2023, will support a residential substance use disorder treatment program for up to 100 adult male inmates incarcerated at the state's medium security facility. The program offers a 4-6 month treatment phase...
- The Kentucky Justice & Public Safety Cabinet received a $296,104 Formula Grant award from the Department of Justice Office of Justice Programs Bureau of Justice Assistance under the Residential Substance Abuse Treatment for State Prisoners (RSAT) program. The goal of the RSAT program is to assist state and local efforts to increase access to evidence-based substance use disorder treatment and reduce overdose deaths in prisons. With this award, the Kentucky Justice & Public Safety Cabinet...
- The West Virginia Division of Administrative Services/Justice and Community Services (DAS/JCS) will administer $302,965 in funding from FY 2022 Residential Substance Abuse Treatment (RSAT) Formula Grant program funds awarded by the U.S. Department of Justice Office of Justice Programs Bureau of Justice Assistance. The grant period is from October 1, 2022 to September 30, 2026. Funds will support the continuation of 10 RSAT therapeutic communities within the West Virginia Division of...
- This federal Formula Grant award from the U.S. Department of Justice's Bureau of Justice Assistance (BJA) provides $118,765 to the DC Office of Victim Services and Justice Grants (OVSJG) to fund the Residential Substance Abuse Treatment (RSAT) for State Prisoners Program (CFDA 16.593). The program aims to address the high rates of substance use disorders and co-occurring mental health conditions among the incarcerated population in Washington, D.C. The grant will support OVSJG in operating a...
- The District of Columbia Office of Victim Services and Justice Grants (DCOVSJG) will receive $139,626 under a Formula Grant award from the Department of Justice Office of Justice Programs Bureau of Justice Assistance Residential Substance Abuse Treatment for State Prisoners program (RSAT). The grant will support the DC Department of Corrections' (DOC) jail-based substance abuse treatment program (RSAT Program) which provides clinically managed low-intensity substance use disorder and...
- The Department of Justice Bureau of Justice Assistance awarded the Arizona Criminal Justice Commission $429,688 on October 1, 2025, under the Residential Substance Abuse Treatment for State Prisoners program (CFDA 16.593) to fund the Arizona RSAT Program through September 30, 2029. The award funds four treatment intervention areas. Pretrial substance use disorder treatment programs incorporate periodic and random urinalysis and other proven drug and alcohol testing. Residential treatment in...
The Bureau of Justice Assistance awarded the Virginia Department of Criminal Justice Services $353,824 on October 1, 2025, under the Residential Substance Abuse Treatment for State Prisoners program (CFDA 16.593) to expand and strengthen substance use disorder treatment and reentry services across Virginia's correctional system. The award funds the Virginia RSAT Program, which delivers structured residential treatment grounded in cognitive behavioral therapy to incarcerated individuals with substance use disorders or co-occurring substance use and mental health disorders in local and regional jails, juvenile detention centers, and state prisons. Services include pre-release case management, peer support specialist coordination, and collaboration with community services boards to ensure continuity of care upon release. Released individuals receive overdose prevention education and naloxone distribution when appropriate, with community-based aftercare programs continuing support post-release. The Virginia Department of Criminal Justice Services will provide technical assistance and monitoring throughout the award period. Performance occurs at the Department's headquarters in Richmond, Virginia, with activities extending across the Commonwealth's correctional facilities and community-based aftercare programs. The award period runs from October 1, 2025, through September 30, 2029. The program targets individuals leaving incarceration who face elevated overdose risk in the immediate post-release period, a critical concern given that overdose deaths remain among Virginia's leading preventable causes of mortality.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $353.8k | 6/25/26 |